ストックスクリーナーアプリを入手
16.01
0.93%
-0.15
前日終値:
$16.16
開ける：
$16.19
24時間の取引高:
1.54M
Relative Volume:
1.08
時価総額：
$1.93B
収益：
$1.12B
当期純損益:
$5.00M
株価収益率:
1,601.00
EPS:
0.01
ネットキャッシュフロー:
$-383.00M
1週間 パフォーマンス:
+3.49%
1か月 パフォーマンス:
+15.18%
6か月 パフォーマンス:
+37.42%
1年 パフォーマンス:
+53.06%
1日の値動き範囲:
$15.97
$16.34
1週間の範囲:
$15.00
$16.34
52週間の値動き範囲:
$7.33
$16.34
Indivior Plc Stock (INDV) Company Profile
INDV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
16.01 | 1.93B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
148.60 | 68.99B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 46.36B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.60 | 44.74B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.06 | 18.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.01 | 13.33B | 2.99B | 1.21B | 1.13B | 25.06 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-07-23 | 開始されました | Piper Sandler | Overweight |
| 2024-04-03 | 開始されました | Craig Hallum | Buy |
| 2023-07-13 | 開始されました | Northland Capital | Outperform |
Indivior Plc (INDV) 最新ニュース
What drives Indivior PLC stock priceUnprecedented profits - Autocar Professional
What analysts say about Indivior PLC stockOverwhelming financial success - Jammu Links News
Is Indivior PLC a good long term investmentPhenomenal capital appreciation - Jammu Links News
Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st - Eastern Progress
Indivior PLC Stock Analysis and ForecastFree Real-Time Stock Data - Jammu Links News
Indivior PLC Executes Share Buyback Plan - TipRanks
Barclays Acquires Significant Stake in Indivior PLC - TipRanks
Indivior to Announce Q2 2025 Financial Results - TipRanks
Indivior to report Q2 2025 results on July 31 - Investing.com
Indivior to report Q2 2025 results on July 31 By Investing.com - Investing.com Nigeria
Indivior Sets Q2 2025 Earnings Release and Live Webcast: Key Details for Investors - Stock Titan
How To Trade (INDV) - news.stocktradersdaily.com
Indivior stock hits 52-week high at 15.9 USD By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 15.9 USD - Investing.com Australia
Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire
Hawaii to receive up to $2.4M in latest opioid settlement - Spectrum News
Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs - PR Newswire
Indivior Strengthens Leadership: Former Sage Therapeutics SVP Joins to Advance Opioid Crisis Solutions - Stock Titan
Shareholders that Lost Money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? - MSN
Indivior stock hits 52-week high at $15.52 - Investing.com Australia
Indivior stock hits 52-week high at $15.52 By Investing.com - Investing.com Canada
Indivior PLC (INDV) Stock Price Up 4.02% on Jul 2 - GuruFocus
Indivior PLC Announces Change in Major Holdings by Barclays - The Globe and Mail
Indivior to join Russell 2000 Index - MSN
BlackRock Increases Stake in Indivior PLC - TipRanks
Indivior PLC Updates Share Capital and Voting Rights - TipRanks
Indivior price target raised to $22 from $16 at Northland - TipRanks
Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes - GuruFocus
Indivior Joins U.S. Russell Indexes, Boosting Market Presence - TipRanks
Indivior appoints Tony Kingsley to board of directors - Investing.com
Two Seas Capital LP Increases Stake in Indivior PLC - GuruFocus
Indivior Appoints Tony Kingsley to the Board of Directors – Company Announcement - Financial Times
Indivior adds biopharmaceutical executive Kingsley to board By Investing.com - Investing.com UK
Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users - Longview News-Journal
Indivior PLC Announces Changes in Major Holdings - TipRanks
Wirral Council v Indivior/Reckitt: Supreme Court refuses permission to appeal representative action strike out - stewartslaw.com
Indivior PLC Corrects Director Shareholding Disclosure - TipRanks
REGIndivior PLCDirector/PDMR ShareholdingCorrection - TradingView
Naloxone Market to Reflect Significant Incremental - openPR.com
Indivior Directors Increase Stake in Company Shares - TipRanks
Suboxone Market Set to Witness Growth as Opioid Dependency - openPR.com
Substance Abuse Treatment Market Size, Trends & Growth - openPR.com
Indivior PLC Announces Changes in Major Shareholdings - MSN
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? - Filter
INDV DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline - ACCESS Newswire
Indivior Plc (INDV) 財務データ
収益
当期純利益
現金流量
EPS
4.65%
大文字化:
|
ボリューム (24 時間):